Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin Type A Injected Into the Temporalis and Masseter Before Orthognathic Surgery to Improve Postoperative Pain

NCT04794504 is registered in ClinicalTrials.gov with Kingsway Oral & Maxillofacial Surgery as lead sponsor.

NCT NCT04794504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04794504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin Type A Injected Into the Temporalis and Masseter Before Orthognathic Surgery to Improve Postoperative Pain
Lead sponsor
Kingsway Oral & Maxillofacial Surgery
Phase
Phase 2
Overall status
Unknown status
Start date
April 19, 2021
Completion date
April 19, 2026
Enrollment
64 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative